Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1993-5-25
|
pubmed:abstractText |
Lipocortin-1 mediates growth inhibition of glucocorticoids in A549 cells by suppressing the release of PGE2 necessary for their proliferation. We now show that 2 peptide fragments derived from the N-terminal portion of lipocortin-1 corresponding to amino-acids 13-25 and 21-33 also inhibited A549 cell growth and suppressed release of PGE2, whereas peptides 1-12 and 13-25 (Phe21; in which the tyrosine at position 21 was replaced by a phenylalanine residue) were inactive. Similarly, peptide 21-33 (Phe21) and a scrambled sequence of 13-25 failed to inhibit cell growth. Moreover, the EGF-induced stimulation of cell proliferation and PGE2 release in these cells was blocked by peptides 13-25 and 21-33, and also by peptides 1-12, 13-25 (Phe21) and 21-33 (Phe21), but not by a scrambled sequence of peptide 13-25.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
22
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
153-8
|
pubmed:dateRevised |
2010-8-25
|
pubmed:meshHeading |
pubmed-meshheading:8478141-Adenocarcinoma,
pubmed-meshheading:8478141-Amino Acid Sequence,
pubmed-meshheading:8478141-Annexin A1,
pubmed-meshheading:8478141-Cell Division,
pubmed-meshheading:8478141-Dinoprostone,
pubmed-meshheading:8478141-Epidermal Growth Factor,
pubmed-meshheading:8478141-Humans,
pubmed-meshheading:8478141-Lung Neoplasms,
pubmed-meshheading:8478141-Molecular Sequence Data,
pubmed-meshheading:8478141-Peptide Fragments,
pubmed-meshheading:8478141-Tumor Cells, Cultured
|
pubmed:year |
1993
|
pubmed:articleTitle |
N-terminal peptide fragments of lipocortin-1 inhibit A549 cell growth and block EGF-induced stimulation of proliferation.
|
pubmed:affiliation |
Department of Biochemical Pharmacology, William Harvey Research Institute, Medical College, St. Batholomew's Hospital, London, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|